Record mula sa primary source
MateryalNaisumite ang aplikasyon
enGene: pivotal cohort 12-month data at BLA filing inaasahan sa 2H 2026
Ayon sa corporate presentation noong Hulyo 2026, ang pivotal cohort 12-month data readout at BLA filing para sa detalimogene voraplasmid ay inaasahan sa ikalawang kalahati ng 2026. Itinatakda nito ang susunod na regulatory milestone bilang isang planadong BLA submission kasunod ng LEGEND study readout.
Mahahalagang fact
- Na-file
- Hul 17, 2026, 08:05 PM
- Kaganapan
- Naisumite ang aplikasyon
- Direksyon
- Neutral
- Kumpanya
ENGNenGene- Pinagmulan
- SEC 8-K
- Kumpiyansa
- May source
Sipi mula sa source
EX-99.1 2 engn-ex99_1.htm EX-99.1 Corporate Presentation Non-Viral Genetic Medicine Disclaimers Cautionary Statement Regarding Forward-Looking Statements This Presentation contains certain forward-looking statements within the meaning of the federal securities laws and "forward-looking information" within the meaning of Canadian securities laws (collectively, "forward-looking statements"). Forward-looking statements may be identified by the use of the words such as “forecast”, “intend”, “develop”, “expect”, “anticipate”, “become”, “believe”, “continue”, “could”, “estimate”, “goal”, “intends”, “may”, “might”, “plan”, “possible”, “project”, “should”, “strategy”, “future”, “potential”, “opportunity”, “target”, “term”, “will”, “would”, “will be” or similar expressions that predict or indicat
Higit pa tungkol sa asset na ito
Materyal
Set 8, 2026
11:33 AM
ENGNenGeneKapansin-pansin
Ago 11, 2026
08:03 PM
ENGNenGeneenGene: LEGEND pivotal cohort 12-month data at BLA filing inaasahang 2H 2026
Materyal
Hul 16, 2026
12:06 PM
ENGNenGeneMateryal
Hun 15, 2026
01:14 PM
ENGNenGeneDecision-grade
May 7, 2026
11:11 AM
ENGNenGeneMateryal
Abr 9, 2026
08:02 PM
ENGNenGeneKapansin-pansin
Mar 9, 2026
11:04 AM
ENGNenGeneenGene: plano ng pag-update sa pivotal cohort ng LEGEND sa medical conference sa tagsibol ng 2026